ReviewAmerican journal of cancer research2024
Leveraging molecular targeted drugs and immune checkpoint inhibitors treat advanced thyroid carcinoma to achieve thyroid carcinoma redifferentiation.
Jing-Yang Su et al.PubMed ↗Full text ↗
No numbers read from the abstract.